During the last session, Ideaya Biosciences Inc (NASDAQ:IDYA)’s traded shares were 1.22 million, with the beta value of the company hitting 0.28. At the end of the trading day, the stock’s price was $16.18, reflecting an intraday loss of -4.71% or -$0.8. The 52-week high for the IDYA share is $44.42, that puts it down -174.54 from that peak though still a striking 16.87% gain since the share price plummeted to a 52-week low of $13.45. The company’s market capitalization is $1.42B, and the average intraday trading volume over the past 10 days was 1.93 million shares, and the average trade volume was 1.13 million shares over the past three months.
Ideaya Biosciences Inc (IDYA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.15. IDYA has a Sell rating from 0 analyst(s) out of 11 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 10 recommend a Buy rating for it.
Ideaya Biosciences Inc (NASDAQ:IDYA) trade information
Ideaya Biosciences Inc (IDYA) registered a -4.71% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -4.71% in intraday trading to $16.18, hitting a weekly high. The stock’s 5-day price performance is 2.53%, and it has moved by -12.40% in 30 days. Based on these gigs, the overall price performance for the year is -61.02%. The short interest in Ideaya Biosciences Inc (NASDAQ:IDYA) is 9.95 million shares and it means that shorts have 10.41 day(s) to cover.
The consensus price target of analysts on Wall Street is $38.5, which implies an increase of 57.97% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $27 and $50 respectively. As a result, IDYA is trading at a discount of -209.02% off the target high and -66.87% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -0.01%. While earnings are projected to return 16.94% in 2025, the next five years will return 15.86% per annum.
IDYA Dividends
Ideaya Biosciences Inc is due to release its next quarterly earnings on 2025-Feb-12. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Ideaya Biosciences Inc (NASDAQ:IDYA)’s Major holders
Ideaya Biosciences Inc insiders own 1.04% of total outstanding shares while institutional holders control 109.56%, with the float percentage being 110.70%. FMR LLC is the largest shareholder of the company, while 290.0 institutions own stock in it. As of 2024-06-30, the company held over 11.27 million shares (or 14.4557% of all shares), a total value of $395.69 million in shares.
The next largest institutional holding, with 6.81 million shares, is of BLACKROCK INC.’s that is approximately 8.7321% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $239.02 million.
